Low Maternal B12 Programs Offspring Obesity Through Gut Bacteria Loss
Vitamin B12 deficiency during pregnancy depletes a key gut microbe in offspring, worsening obesity — and restoring it reverses the damage.
Summary
A new Cell Metabolism study shows that when mothers lack adequate vitamin B12 during pregnancy and breastfeeding, their offspring are more vulnerable to obesity later in life. The culprit appears to be a dramatic reduction in a beneficial gut bacterium called Bifidobacterium pseudolongum, which is normally passed from mother to baby during nursing. Without enough of this microbe, offspring exposed to a high-fat diet develop worse metabolic dysregulation. Remarkably, restoring B. pseudolongum — or simply supplementing its main byproduct, a short-chain fatty acid called acetate — largely reversed this metabolic damage. The acetate works through a specific receptor (Ffar2) to activate a metabolic gene (Ehhadh). This research identifies a critical lactation window in which maternal nutrition shapes lifelong metabolic health in children via gut microbiome seeding.
Detailed Summary
Vitamin B12 deficiency during pregnancy and breastfeeding is widespread globally, yet its downstream effects on children's long-term metabolic health have been poorly understood. This study in Cell Metabolism provides a compelling mechanistic explanation — one that links maternal nutrition, gut microbiome transmission, and offspring obesity risk in a unified biological pathway.
Researchers at Chongqing Medical University used a dietary deprivation model to investigate what happens when mothers consume insufficient vitamin B12. They found that B12-deprived mothers not only experienced impaired glucose metabolism and worse reproductive outcomes, but also passed on a depleted gut microbiome to their pups. The most consequential loss was Bifidobacterium pseudolongum, a beneficial bacterium markedly reduced in both mothers and offspring.
The study reveals that the lactation period is a critical window for microbiome transmission. Offspring that failed to acquire adequate B. pseudolongum early in life went on to develop significantly more severe obesity and metabolic dysfunction when later challenged with a high-fat diet. This points to a form of metabolic imprinting driven not by genetics but by microbial inheritance shaped by maternal diet.
Crucially, the researchers found that the damage is reversible. Early-life restoration of B. pseudolongum, or supplementation with acetate — the bacterium's key metabolic byproduct — effectively ameliorated the aggravated obesity. Mechanistically, acetate activates the Ffar2 receptor, which in turn upregulates expression of Ehhadh, a gene involved in fatty acid metabolism.
These findings carry significant implications for prenatal and perinatal nutrition guidelines. Ensuring adequate maternal B12 intake may be a tractable intervention to protect offspring microbiome colonization and reduce intergenerational obesity risk. Limitations include that this is a preclinical animal study and the full summary is based on the abstract only.
Key Findings
- Maternal B12 deficiency during pregnancy and lactation significantly worsens obesity risk in offspring via gut microbiome depletion.
- B. pseudolongum, a beneficial gut bacterium, is markedly reduced in B12-deficient mothers and is poorly transmitted to offspring during nursing.
- Restoring B. pseudolongum or supplementing acetate in early life reverses the aggravated obesity phenotype in offspring.
- Acetate activates the Ffar2 receptor to upregulate Ehhadh, linking microbial metabolites to fatty acid metabolism.
- Lactation is identified as a critical window for microbiome seeding that imprints lifelong metabolic health.
Methodology
This appears to be a preclinical mouse study using a maternal dietary vitamin B12 deprivation model combined with high-fat diet challenges in offspring. Researchers performed gut microbiome analysis, metabolic phenotyping, microbial restoration experiments, and mechanistic studies involving receptor and gene expression analysis. Full methodology is not available as only the abstract was accessible.
Study Limitations
This is a preclinical animal study; direct translation to human pregnancy and infant outcomes requires further investigation. The mechanistic findings (Ffar2/Ehhadh pathway) have not been validated in human cohorts. The summary is based on the abstract only, and full study design, sample sizes, and statistical methods could not be reviewed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: